早期肺癌淋巴结分期质量改善:国家癌症数据库分析
该研究利用国家癌症数据库分析2004至2013年间接受肺段或肺叶切除的临床I期非小细胞肺癌患者,评估淋巴结评估质量的变化及相关因素。结果显示平均清扫淋巴结数从8.1枚增至10.0枚,清扫0-5枚的比例下降,超过15枚的比例上升,学术中心更少仅清扫0-5枚,清扫超过14枚与更高的淋巴结分期迁移相关。
要点
- 早期肺癌淋巴结评估质量自2004年改善,平均清扫数由8.1增至10.0枚。
- 学术中心较少仅清扫0-5枚淋巴结(27.2% vs 社区43.6%)。
- 清扫至少14枚淋巴结与更高的淋巴结分期迁移相关(17.9% vs 10.9%)。
核心结论
- 自2004年以来早期非小细胞肺癌的淋巴结评估有所改善,但受机构类型等因素影响而存在差异。
- 清扫至少14枚淋巴结与更准确的分期相关。
研究设计与样本
- 回顾性队列研究,查询国家癌症数据库,纳入2004至2013年间接受肺段切除或肺叶切除的临床I期非小细胞肺癌患者,共51,358例。
- 按清扫淋巴结数目分为≤5枚、6-15枚和>15枚三组。
主要发现
- 研究期间平均清扫淋巴结数从8.1枚增至10.0枚(p < 0.001)。
- 清扫0-5枚淋巴结的患者比例从41.1%降至31.1%(p < 0.001),清扫超过15枚的比例从10.1%升至17.0%(p < 0.001)。
- 学术中心患者仅清扫0-5枚淋巴结的比例为27.2%,低于社区医院的43.6%(p < 0.001)。
- 清扫超过15枚淋巴结的相关因素包括年份增加、年龄大于65岁、男性、非非洲裔美国人、学术中心、肺叶切除和临床T2期。
- 清扫超过14枚淋巴结的患者淋巴结分期迁移率为17.9%,高于清扫1-14枚的10.9%(p < 0.001)。
关键数值与推荐
- 多变量分析提示应至少清扫14枚淋巴结以最大化正确识别淋巴结阳性患者的概率。
临床怎么用
- 在早期非小细胞肺癌手术中,应争取清扫至少14枚淋巴结以提高分期准确性。
- 应关注不同机构类型间淋巴结评估质量的差异,促进标准化。
局限性
- 本研究为基于国家癌症数据库的回顾性分析,可能存在选择偏倚和未测量混杂因素。
- 数据库可能未涵盖所有影响淋巴结评估的临床细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymph node assessment for non-small cell lung cancer (NSCLC) shows wide variation among centers. Our aim was to assess the quality of lymph node assessment in early-stage NSCLC and determine whether any factors are associated with improved lymph node harvest. METHODS: We queried the National Cancer Database to identify patients with clinical stage I NSCLC who underwent segmentectomy or lobectomy between 2004 and 2013. Patients were stratified into three groups (≤5, 6 to 15, and >15) based on the number of lymph nodes assessed. RESULTS: Patients (n = 51,358) met criteria, and mean lymph nodes assessed increased from 8.1 to 10.0 (p < 0.001) over the study period. There was a significant decrease in the percentage of patients with 0 to 5 nodes assessed (41.1% versus 31.1%, p < 0.001) and a significant increase in patients with more than 15 nodes assessed (10.1% versus 17.0%, p < 0.001). Patients at academic centers were less likely to have only 0 to 5 nodes assessed (27.2% versus 43.6% for community, p < 0.001). Variables associated with more than 15 nodes assessed were increasing year, age older than 65 years, male sex, non-African American race, academic centers, lobectomy, and clinical T2 disease. Patients with more than 14 nodes assessed demonstrated more nodal upstaging (17.9% versus 10.9% for 1 to 14 nodes, p < 0.001). Multivariable analysis suggests that at least 14 nodes should be assessed to maximize the probability that node-positive patients are correctly identified. CONCLUSIONS: Lymph node assessment has improved since 2004 but varies by facility type and other characteristics. In our analysis removing at least 14 nodes was associated with more accurate staging.
引用
- Krantz SB, Lutfi W, Kuchta K, et al. Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database. Ann Thorac Surg. 2017. PMID: 29102039. doi:10.1016/j.athoracsur.2017.06.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。